Article
Siglec10 as an Immunosuppressive and Tumorgenesis Signature for Prediction of Survival Prognosis in Gliomas
2020-07-22
Abstract excerpt
<title>Abstract</title> <p><bold>Background </bold>Glioma is a type of tumor occurring in central nervous system. Specific factors mutations and molecular abnormalities are used to conduct glioma classification and clinical decision in recent decade. Siglec10 is a member of sialic acid binding immunoglobulin superfamily. <bold>Methods </bold>We analyzed the siglec10 expression in glioma patients with immunohistoc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dc952d51-0dd0-52f7-8775-2603c358cb4d
- DOI
- 10.21203/rs.3.rs-44913/v1